Ralf Huss;Manfred J. Stangl, SR.;Peter C. Nelson;Matthias C. Raggi
发明人:
Ralf Huss,Peter C. Nelson,Matthias C. Raggi,Manfred J. Stangl, SR.
申请号：
US14707872
公开号：
US20150238541A1
申请日:
2015.05.08
申请国别(地区):
US
年份:
2015
代理人:
摘要：
This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34 stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34 stem cells used in the instant methods can be genetically, modified or not, depending on the disorder treated.
